<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="correction">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJMM</journal-id>
<journal-title-group>
<journal-title>International Journal of Molecular Medicine</journal-title></journal-title-group>
<issn pub-type="ppub">1107-3756</issn>
<issn pub-type="epub">1791-244X</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/ijmm.2026.5889</article-id>
<article-id pub-id-type="publisher-id">ijmm-58-02-05889</article-id>
<article-categories>
<subj-group>
<subject>Corrigendum</subject></subj-group></article-categories>
<title-group>
<article-title>[Corrigendum] (-)-Epigallocatechin-3-gallate attenuates myocardial injury induced by ischemia/reperfusion in diabetic rats and in H9c2 cells under hyperglycemic conditions</article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Wu</surname><given-names>Yang</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>Xia</surname><given-names>Zhong-Yuan</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>Zhao</surname><given-names>Bo</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>Leng</surname><given-names>Yan</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>Dou</surname><given-names>Juan</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>Meng</surname><given-names>Qing-Tao</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>Lei</surname><given-names>Shao-Qing</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>Chen</surname><given-names>Zhi-Ze</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>Zhu</surname><given-names>Jie</given-names></name></contrib></contrib-group>
<pub-date pub-type="collection">
<month>08</month>
<year>2026</year></pub-date>
<pub-date pub-type="epub">
<day>10</day>
<month>06</month>
<year>2026</year></pub-date>
<volume>58</volume>
<issue>2</issue>
<elocation-id>218</elocation-id>
<permissions>
<copyright-statement>Copyright: &#x000A9; 2026 Wu et al.</copyright-statement>
<copyright-year>2026</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license></permissions></article-meta></front>
<body>
<p>Int J Mol Med 40: <related-article id="RA1" related-article-type="corrected-article" vol="40" page="389" ext-link-type="doi" xlink:href="10.3892/ijmm.2017.3014">389-399</related-article>, 2017; DOI: 10.3892/ijmm.2017.3014</p>
<p>Following the publication of the above article, an interested reader drew to the authors' attention that, concerning the Masson trichrome-stained sections of left ventricles shown in <xref rid="f6-ijmm-58-02-05889" ref-type="fig">Fig. 6A</xref> on p. 395, a portion of the panel representing the DM+EGCG group (centre panel) contained an overlapping area with a portion of the panel from the DM group (second panel on the left), which was representative of the experiment that lacked EGCG treatment.</p>
<p>Upon investigating this figure, the authors have realized that the affected data panels were inadvertently assembled incorrectly. This error arose due to an oversight in image selection made during figure assembly. A revised version of <xref rid="f6-ijmm-58-02-05889" ref-type="fig">Fig. 6</xref>, now showing the correct data panel for the DM+EGCG group (centre panel) in <xref rid="f6-ijmm-58-02-05889" ref-type="fig">Fig. 6A</xref>, is shown on the next page. Also note that the published version of <xref rid="f6-ijmm-58-02-05889" ref-type="fig">Fig. 6A</xref> did not feature labels portraying the different experimental groups in this figure part, and these are now included in the revised figure to improve its clarity.</p>
<p>The authors confirm that the error associated with this figure did not have any significant impact on either the results or the conclusions reported in this study, and all the authors agree with the publication of this Corrigendum. The authors are grateful to the Editor of <italic>International Journal of Molecular Medicine</italic> for allowing them the opportunity to publish this Corrigendum; furthermore, they apologize to the readership of the Journal for any inconvenience caused.</p></body>
<floats-group>
<fig id="f6-ijmm-58-02-05889" position="float">
<label>Figure 6</label>
<caption>
<p>(-)-Epigallocatechin gallate (EGCG) treatment reduces the extent of cardiac fibrosis in the diabetic rats following ischemia/reperfusion (I/R) injury. (A) Masson trichrome-stained sections of left ventricles. (B) Quantification of cardiac fibrosis area from Masson trichrome-stained sections. Values are the means &#x000B1; SEM. n=5. <sup>&#x0002A;</sup>P&lt;0.05 vs. control group; <sup>#</sup>P&lt;0.05 vs. DM group; <sup>$</sup>P&lt;0.05 vs. DM + EGCG group.</p></caption>
<graphic xlink:href="ijmm-58-02-05889-g00.tif"/></fig></floats-group></article>
